NCT00829595View on ClinicalTrials.gov

Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Inflammatory Bowel DiseaseCrohn DiseaseUlcerative Colitis
Interventions
BIOLOGICAL

23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)

0.5mL intramuscular, one time

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT00829595 - Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter